CC(=O)N1CCc2nc3sc(C(=O)Nc4ccc(Cl)cc4F)c(N)c3c(C(F)(F)F)c2C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?